Literature DB >> 28056381

Vineland-II adaptive behavior profile of children with attention-deficit/hyperactivity disorder or specific learning disorders.

Giulia Balboni1, Oriana Incognito2, Carmen Belacchi3, Sabrina Bonichini4, Roberto Cubelli5.   

Abstract

BACKGROUND: The evaluation of adaptive behavior is informative in children with attention-deficit/hyperactivity disorder (ADHD) or specific learning disorders (SLD). However, the few investigations available have focused only on the gross level of domains of adaptive behavior. AIMS: To investigate which item subsets of the Vineland-II can discriminate children with ADHD or SLD from peers with typical development. METHODS AND PROCEDURES: Student's t-tests, ROC analysis, logistic regression, and linear discriminant function analysis were used to compare 24 children with ADHD, 61 elementary students with SLD, and controls matched on age, sex, school level attended, and both parents' education level.
RESULTS: Several item subsets that address not only ADHD core symptoms, but also understanding in social context and development of interpersonal relationships, allowed discrimination of children with ADHD from controls. The combination of four item subsets (Listening and attending, Expressing complex ideas, Social communication, and Following instructions) classified children with ADHD with both sensitivity and specificity of 87.5%. Only Reading skills, Writing skills, and Time and dates discriminated children with SLD from controls.
CONCLUSIONS: Evaluation of Vineland-II scores at the level of item content categories is a useful procedure for an efficient clinical description.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADHD; Adaptive behavior profile; Matching; SLD; Vineland

Mesh:

Year:  2017        PMID: 28056381     DOI: 10.1016/j.ridd.2016.12.003

Source DB:  PubMed          Journal:  Res Dev Disabil        ISSN: 0891-4222


  6 in total

1.  Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor Encephalitis.

Authors:  Anusha Yeshokumar; Eliza Gordon-Lipkin; Ana Arenivas; Mark Rosenfeld; Kristina Patterson; Raia Blum; Brenda Banwell; Arun Venkatesan; Eric Lancaster; Jessica Panzer; John Probasco
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-07-06

2.  Analysis of a Repetitive Language Coding System: Comparisons between Fragile X Syndrome, Autism, and Down Syndrome.

Authors:  Anne Hoffmann; Angela John Thurman; Audra Sterling; Sara T Kover; Lizabeth Finestack; Elizabeth Berry-Kravis; Jamie O Edgin; Andrea Drayton; Eric Fombonne; Leonard Abbeduto
Journal:  Brain Sci       Date:  2022-04-29

3.  Concurrent Validity of the ABAS-II Questionnaire with the Vineland II Interview for Adaptive Behavior in a Pediatric ASD Sample: High Correspondence Despite Systematically Lower Scores.

Authors:  Annie Dupuis; Michael J Moon; Jessica Brian; Stelios Georgiades; Tomer Levy; Evdokia Anagnostou; Rob Nicolson; Russell Schachar; Jennifer Crosbie
Journal:  J Autism Dev Disord       Date:  2021-05

4.  Cerebellar involvement in warts Hypogammaglobulinemia immunodeficiency myelokathexis patients: neuroimaging and clinical findings.

Authors:  Jessica Galli; Lorenzo Pinelli; Serena Micheletti; Giovanni Palumbo; Lucia Dora Notarangelo; Vassilios Lougaris; Laura Dotta; Elisa Fazzi; Raffaele Badolato
Journal:  Orphanet J Rare Dis       Date:  2019-02-28       Impact factor: 4.123

5.  Time of onset and/or diagnosis of ADHD in European children: a systematic review.

Authors:  Ilaria Rocco; Barbara Corso; Maurizio Bonati; Nadia Minicuci
Journal:  BMC Psychiatry       Date:  2021-11-16       Impact factor: 3.630

6.  Trajectories of Adaptive Behaviors During Childhood in Females and Males in the General Population.

Authors:  Tomoko Nishimura; Takeo Kato; Akemi Okumura; Taeko Harada; Toshiki Iwabuchi; Md Shafiur Rahman; Tomoya Hirota; Michio Takahashi; Masaki Adachi; Hitoshi Kuwabara; Shu Takagai; Yoko Nomura; Nagahide Takahashi; Atsushi Senju; Kenji J Tsuchiya
Journal:  Front Psychiatry       Date:  2022-03-23       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.